A. Hall, J. Blomet, L. Mathieu
Jan 1, 2003
Citations
0
Influential Citations
4
Citations
Journal
Journal of Toxicology: Clinical Toxicology
Abstract
The publication of ‘‘Topical Treatments for Hydrofluoric Acid Burns: A Blind Controlled Experimental Study’’ by Höjer et al. (1) has raised the issue of whether the active, amphoteric, hypertonic, specific eye=skin hydrofluoric acid (HF) decontaminant, Hexafluorine, is appropriate for use in emergent decontamination of HF eye=skin splashes. As is not unexpected, there will be a number of studies, and sometimes one study may have negative results. A weight-of-the-evidence approach should be used by all those who must make decisions about proper decontamination and treatment of workers having eye=skin chemical splashes. What have Höjer et al. actually studied? They have studied treatment of HF burns in a rat model rather than decontamination of HF splashes, and they did excellent work in a well-designed study. However, with a 3-min contact time of 50% HF and a 30-s delay to decontamination with water or Hexafluorine, and treatment with water only followed by a single inunction of 2.5% calcium gluconate, it would be highly unlikely that any decontamination measure would be efficacious, and all that was actually studied is treatment with topical calcium gluconate, which has been repeatedly demonstrated to be efficacious in workers with occupational HF exposure or in experimental animal studies (2–5). The anesthetized domestic pig model has been shown to have good applicability for evaluating dermal lesions due to 38% HF exposure (6,7). In preliminary studies coordinated between Honeywell (the major producer of HF in North America and a producer of HF in Europe) and Laboratoire Prevor (manufacturer of Hexafluorine) in a reputable research laboratory using this pig model, exposure to 49% HF for as little as 5–10 s produces significant HF burns. In this same model, contact with 49% HF for 3 min produces immediate blanching apparent at the time the applicator is removed from the skin, followed by necrosis. The American National Standard for Emergency Eyewash and Shower Equipment (ANSI Z358.1-1998) states in Appendix B, B5, Placement of Emergency Equipment: ‘‘Emergency eyewash and shower equipment should be available for immediate use, but in no instance should it take an individual longer than 10 s to reach the nearest facility’’ (8). Emergent decontamination with Hexafluorine is recommended by Laboratoire Prevor within the first few seconds following HF exposure. Skin exposure to 50% HF produces pain nearly instantly; therefore, a skinexposed worker is highly unlikely to wait 3 min before beginning decontamination, whether with water or Hexafluorine. The experimental protocol of Höjer et al. is thus unrealistic in regard to workplace HF skin splashes. The experimental results in rats obtained with a 3-min 50% HF contact time followed by 30 s of delay to decontamination were not much different between water and Hexafluorine. It would have been interesting to test an experimental group of Hexafluorine decontamination plus topical calcium gluconate to compare this group with water decontamination plus calcium gluconate, but this was not done by Höjer et al. In workers exposed to HF and decontaminated with Hexafluorine, the results have been universally positive. Hexafluorine is a solution that has been especially developed to decontaminate HF splashes and specifically binds both Hþ and F ions. Reports published or presented at peer-reviewed scientific meetings in the United States and Europe have shown that Hexafluorine emergent decontamination is associated with no HF burns developing or with significantly less burns than have been associated with